Pregnyl 1500 Organon Pharmaceuticals: Compound Profile
Pregnyl 1500 is a pharmaceutical-grade human chorionic gonadotropin (hCG) formulation manufactured by Organon Pharmaceuticals, containing 1500 International Units per ampoule. This glycoprotein hormone shares structural similarities with luteinising hormone and serves as a critical research tool in reproductive endocrinology studies. Research laboratories at Stroid UK Shop examine hCG’s dual receptor interactions and molecular signalling pathways in controlled experimental environments. The compound’s pharmaceutical manufacturing standards ensure consistent potency and purity for analytical investigations across diverse research protocols.
Laboratory Applications
Research scientists investigate Pregnyl’s interaction with luteinising hormone/choriogonadotropin receptors in cellular models to understand gonadotropin signalling mechanisms. Studies examine the compound’s effects on steroidogenesis pathways, particularly testosterone biosynthesis regulation in Leydig cell cultures. Comparative analyses between hCG and endogenous luteinising hormone reveal distinct pharmacodynamic profiles in receptor binding assays. Post cycle therapy research protocols utilise this compound to evaluate hypothalamic-pituitary-gonadal axis modulation in experimental models. Advanced laboratories investigate molecular weight variants and glycosylation patterns affecting biological activity. Research methodologies include enzyme-linked immunosorbent assays, receptor binding studies, and steroid hormone quantification. SARMs interaction studies examine potential synergistic effects on androgen receptor pathways. Comparative endocrinology research evaluates species-specific responses to exogenous gonadotropin administration in controlled environments.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Human Chorionic Gonadotropin |
| Strength | 1500 IU per ampoule |
| Molecular Weight | 36.7 kDa (approximate) |
| CAS Number | 9002-61-3 |
| Manufacturer | Organon Pharmaceuticals |
| Form | Lyophilised powder |
| Storage | 2-8°C, protect from light |
| Reconstitution | Sterile water for injection |
Quality control laboratories verify biological activity through bioassays and immunological methods. Peptides research facilities utilise complementary hormone studies to understand complex endocrine interactions. Analytical methods include high-performance liquid chromatography and mass spectrometry for purity confirmation.
Research Compliance
This product is manufactured for in-vitro research purposes exclusively. Laboratory personnel must ensure proper storage conditions and handle according to institutional biosafety protocols. Research applications require appropriate ethical approvals and adherence to good laboratory practices. This compound is not intended for human consumption or therapeutic applications outside of controlled laboratory environments.
